U.S. Markets open in 3 hrs 24 mins

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
73.76+0.34 (+0.46%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close73.42
Bid73.32 x 600
Ask74.48 x 100
Day's Range73.28 - 74.41
52 Week Range63.76 - 88.85
Avg. Volume8,651,084
Market Cap96.38B
PE Ratio (TTM)7.80
Earnings DateN/A
Dividend & Yield2.08 (2.82%)
Ex-Dividend Date2017-06-14
1y Target EstN/A
Trade prices are not sourced from all markets
  • InPlay from Briefing.com
    Briefing.com10 minutes ago

    InPlay from Briefing.com

    InPlay from Briefing.com

  • Reuters2 hours ago

    HIV fight advances with new drug cocktails, fresh vaccine hopes

    Three decades after approval of the first-ever AIDS treatment, HIV medicine is seeing a new wave of innovation with scientists reporting positive data on Monday for improved drug cocktails and a novel experimental vaccine. The Achilles heel for us is drug resistance because the virus is incredibly quick to mutate," Linda-Gail Bekker, deputy director of the Desmond Tutu HIV Centre in South Africa, said. The race for better and more convenient medicines has made HIV a rich battleground for drug companies such as Gilead Sciences and GlaxoSmithKline, which generate billions of dollars from modern therapies.

  • TheStreet.com16 hours ago

    The Worm Has Turned in Biotech's Favor

    But this needs to heat up again for the sector to rally in a big way.